|
FKBP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.236500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.654200E-02 |
| Normal-vs-Stage2 |
5.454200E-01 |
| Normal-vs-Stage3 |
3.156600E-01 |
| Normal-vs-Stage4 |
2.503000E-01 |
| Stage1-vs-Stage2 |
2.717800E-01 |
| Stage1-vs-Stage3 |
5.307800E-01 |
| Stage1-vs-Stage4 |
9.460400E-01 |
| Stage2-vs-Stage3 |
6.963400E-01 |
| Stage2-vs-Stage4 |
5.063200E-01 |
| Stage3-vs-Stage4 |
7.858800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.216100E-02 |
| Normal-vs-AfricanAmerican |
4.926400E-02 |
| Normal-vs-Asian |
1.998740E-03 |
| Caucasian-vs-AfricanAmerican |
3.644000E-01 |
| Caucasian-vs-Asian |
7.055300E-03 |
| AfricanAmerican-vs-Asian |
7.614300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.889800E-02 |
| Normal-vs-Female |
7.540100E-02 |
| Male-vs-Female |
9.182600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.716000E-02 |
| Normal-vs-Extreme_Weight |
2.600000E-02 |
| Normal-vs-Obese |
2.380200E-01 |
| Normal-vs-Extreme_Obese |
2.659000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.583000E-01 |
| Normal_Weight-vs-Obese |
3.809400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.883000E-01 |
| Extreme_Weight-vs-Obese |
2.039000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.063800E-01 |
| Obese-vs-Extreme_Obese |
6.226800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.440300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.905500E-02 |
| Normal-vs-Age(61-80Yrs) |
9.425900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.808600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.891760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.232300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.891700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.993400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.647810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.606000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.992200E-04 |
| Normal-VS-Type2 PRCC |
8.063600E-01 |
| Normal-VS-KIRP CIMP |
1.523360E-01 |
| Normal-VS-Unclassified PRCC |
8.851200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.56060000051129E-07 |
| Type1 PRCC-VS-KIRP CIMP |
7.651800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.784000E-04 |
| Type2 PRCC-VS-KIRP CIMP |
9.332000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.340000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.345020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.628000E-01 |
| Normal-vs-N1 |
1.315900E-02 |
| Normal-vs-N2 |
5.560400E-02 |
| N0-vs-N1 |
2.993900E-02 |
| N0-vs-N2 |
2.789500E-02 |
| N1-vs-N2 |
1.316450E-02 |
|
|
